Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma

Authors: Gross, Daniel J., Chintala, Navin K., Vaghjiani, Raj G., Grosser, Rachel, Tan, Kay See, Li, Xiaoyu, Choe, Jennie, Li, Yan, Aly, Rania G., Emoto, Katsura, Zheng, Hua, Dux, Joseph, Cheema, Waseem, Bott, Matthew J., Travis, William D., Isbell, James M., Li, Bob T., Jones, David R., Adusumilli, Prasad S.

Source: In Journal of Thoracic Oncology January 2022 17(1):89-102

CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials

Authors: Chintala, Navin K., Restle, David, Quach, Hue, Saini, Jasmeen, Bellis, Rebecca, Offin, Michael, Beattie, Jason, Adusumilli, Prasad S. ^*

Source: In Lung Cancer July 2021 157:48-59

Driving CARs on the uneven road of antigen heterogeneity in solid tumors

Authors: Chen, Nan, Li, Xiaoyu, Chintala, Navin K, Tano, Zachary E, Adusumilli, Prasad S

Source: In Current Opinion in Immunology April 2018 51:103-110

Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies

Authors: Kiesgen, Stefan, Chicaybam, Leonardo, Chintala, Navin K., Adusumilli, Prasad S.

Source: In Journal of Thoracic Oncology January 2018 13(1):16-26

Ex vivo pleural effusion cultures to study chimeric antigen receptor T cell cytotoxicity in an immunocompetent environment

Authors: Tano, Zachary E., Kiesgen, Stefan, Chintala, Navin K., Dozier, Jordan, Quach, Hue Tu, Messinger, John, Tan, Kay See, Adusumilli, Prasad S.

Source: In Cell Reports Methods 20 November 2023 3(11)

Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.

Authors: Chintala, Navin K., Choe, Jennie K., McGee, Erin, Bellis, Rebecca, Saini, Jasmeen K., Banerjee, Srijita, Moreira, Andre L., Zauderer, Marjorie G., Adusumilli, Prasad S., Rusch, Valerie W.

Source: Frontiers in Immunology; 2/16/2023, Vol. 14, p1-19, 19p

Subject Terms: PLEURAL effusions, VACCINIA, PLEURA cancer, IMMUNE checkpoint proteins, NON-small-cell lung carcinoma, CLINICAL trials, MESOTHELIOMA

Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity.

Authors: Kiesgen, Stefan, Messinger, John C., Chintala, Navin K., Tano, Zachary, Adusumilli, Prasad S.

Source: Nature Protocols; Mar2021, Vol. 16 Issue 3, p1331-1342, 12p

Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy.

Authors: Li, Xiaoyu, Eguchi, Takashi, Aly, Rania G., Chintala, Navin K., Tan, Kay See, Zauderer, Marjorie G., Dembitzer, Francine R., Beasley, Mary Beth, Ghebrehiwet, Berhane, Adusumilli, Prasad S., Peerschke, Ellinor I. B.

Source: Frontiers in Oncology; 10/11/2019, p1-15, 15p

Subject Terms: TUMOR classification, MESOTHELIOMA, CANCER chemotherapy

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Ex vivopleural effusion cultures to study chimeric antigen receptor T cell cytotoxicity in an immunocompetent environment

Authors: Tano, Zachary E., Kiesgen, Stefan, Chintala, Navin K., Dozier, Jordan, Quach, Hue Tu, Messinger, John, Tan, Kay See, Adusumilli, Prasad S.

Source: Cell Reports Methods; November 2023, Vol. 3 Issue: 11

Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma

Authors: Gross, Daniel J., Chintala, Navin K., Vaghjiani, Raj G., Grosser, Rachel, Tan, Kay See, Li, Xiaoyu, Choe, Jennie, Li, Yan, Aly, Rania G., Emoto, Katsura, Hua, Zheng, Dux, Joseph, Cheema, Waseem, Bott, Matthew J., Travis, William D., Isbell, James M., Li, Bob T., Jones, David R., Adusumilli, Prasad S.

Source: Journal of Thoracic Oncology; 20210101, Issue: Preprints